Among malignant tumors, the incidence and mortality of lung cancer rank first.

As we all know, smoking is harmful to health. One of the high-risk pathogenic factors that can lead to lung cancer is smoking. But from the global big data, in reality, only a few smokers will suffer from lung cancer.

Why don’t most smokers get lung cancer?

 Does this mean that smoking has no effect on the lungs? A new study recently revealed the truth.

New research reveals the relationship between smoking and lung cancer;

Recently, a study published in Nature Genetics, a sub-issue of the British authoritative medical journal Nature, pointed out that some people who smoke for a long time may have a strong self-protection mechanism to limit the DNA mutation caused by smoking, thus reducing the chance of lung cancer.

The main findings of this study are as follows:

DNA mutation will accumulate in lung cells with the increase of age and smoking, and the probability of DNA mutation in smokers is higher than that in non-smokers. That is to say, excluding other factors, compared with smokers, non-smokers are less likely to get lung cancer, while 10%~20% lifelong smokers are more likely to get lung cancer. Previous studies have also confirmed that smoking can trigger DNA mutation of normal lung cells and lead to lung cancer.

When the number of smokers reaches 23 packs per year (1 pack per year: the number of smoking packs per day x the number of smoking years), the trend of DNA mutation will be stable. Researchers pointed out that when the smoking amount exceeds a certain critical point, it will trigger the self-protection mechanism in smokers and enter the stable period of DNA mutation. It is this powerful DNA repair ability that helps to resist the smoking damage that leads to lung cancer. Therefore, many smokers don’t suffer from lung cancer in the end.

Although the above research provides reasons for some “flukes” who refuse to quit smoking, the purpose of the research is to test the DNA repair ability of individuals to judge the risk of lung cancer.

China has the largest lung cancer country. Can hydrogen prevent and treat lung cancer?

At present, lung cancer has become the leading cause of cancer death in China, and its morbidity and mortality have increased rapidly, especially in recent ten years. According to the national cancer statistics released by China Cancer Center, the new cases of lung cancer account for about one-fifth of the cases of malignant tumors in China, and the death toll accounts for about one-fourth of the cases of malignant tumors. This is a very terrible data. So it’s very important to prevent lung cancer!

Anyone who knows about hydrogen medicine may know that hydrogen may play a certain role in tumor and cancer prevention and treatment. Some people have even read the summary book of hydrogen inhalation cases of cancer patients edited by Professor Xu Kecheng-“Hydrogen Control Cancer”. So, can hydrogen prevent and cure lung cancer?

Hydrogen protects lung, which has a positive effect on the prevention and treatment of lung diseases, or includes lung cancer!

When it comes to protecting the lungs with hydrogen, we know that inhaling hydrogen is to take hydrogen into the blood of the body through gas exchange in the respiratory system. In the process of inhaling hydrogen, at first, the lungs are filled with a certain concentration of hydrogen, which will directly act on the cells of the lungs, repair the damaged cells in time and reduce the inflammatory reaction of lung tissues.

Smoking, air pollution and chronic lung infection are all risk factors for lung cancer. At present, many studies have shown the effect of hydrogen on lung diseases, for example, it can reduce lung inflammation and reduce lung problems caused by smoking; Can relieve symptoms of diseases such as emphysema; There are also crowd studies that confirm that hydrogen can reduce the harm of smog to the lungs.

Academician Zhong Nanshan also mentioned in a media interview that hydrogen has a strong anti-oxidative stress effect, and has obvious intervention and prevention effects on lung diseases such as pneumonia.Hydrogen inhalation machine Poland hot sale home use hydrogen inhaler

Hydrogen may also have a good use for patients with diagnosed lung cancer, even those with metastatic lung cancer.
Clinical studies have found that hydrogen inhalation can cooperate with chemotherapy and targeted therapy, reduce the adverse reactions of patients and improve the quality of life of patients with lung cancer. In June 2020, Professor Xu Kecheng’s team published a research paper in Medical Gas Research. The results showed that hydrogen combined with common cancer treatments can be used to control the cancer progression of patients with advanced non-small cell lung cancer and reduce the adverse events of various standard treatments.

Animal experimental studies have also found that hydrogen inhalation can inhibit the enlargement and increase of metastatic foci of lung cancer, which also means that it can prolong the life of patients as much as possible.

A real-world observation of “Hydrogen Controlled Cancer”: a follow-up report of 82 patients with advanced cancer published in Medical Gas Research, which observed and analyzed 82 patients with self-absorbed hydrogen in stage III and IV, found that hydrogen can improve the quality of life, improve physical fitness, reduce tumor markers and control cancer progression.

After 2 weeks of hydrogen inhalation, shortness of breath and appetite were improved, and fatigue and insomnia were significantly improved. Pain, constipation and diarrhea were significantly improved after 4 weeks of hydrogen inhalation.

After 3 months of hydrogen inhalation, the physical fitness of patients with lung cancer is the most significant, while that of patients with gynecology and pancreatic cancer is the worst.

After 3 months of hydrogen inhalation, the markers of lung cancer patients decreased most obviously, while those of gynecology, liver and pancreatic cancer had the worst effect.

After 3 months of hydrogen inhalation, the tumor control rate of patients in stage I was much higher than that in stage IV, with lung cancer having the best effect and pancreatic cancer having the worst effect.